Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age

被引:39
作者
Halperin, SA
Scheifele, D
Barreto, L
Pim, C
Guasparini, R
Medd, L
Meekison, W
Eastwood, BJ
机构
[1] Dalhousie Univ, Halifax, NS, Canada
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] Pasteur Merieux Connaught, N York, ON, Canada
[4] Calgary Hlth Serv, Calgary, AB, Canada
[5] Cent Fraser Hlth Dist, Fraser Valley, BC, Canada
[6] Simon Fraser Hlth Dist, Fraser Valley, BC, Canada
[7] Boundary Hlth Dist, Fraser Valley, BC, Canada
[8] Univ Auckland, Auckland 1, New Zealand
关键词
Bordetella pertussis; whooping cough; acellular pertussis vaccine;
D O I
10.1097/00006454-199909000-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background and objectives. Acellular pertussis vaccines are now preferred for all five childhood immunization doses; however, there are few data on the safety and immunogenicity of five consecutive doses. This study compared a fifth dose of an acellular and a whole cell pertussis vaccine in 4- to 6-year old children previously immunized with four doses of acellular or whole cell pertussis vaccine. Study design. In a double blind, multicenter study, 366 healthy children were randomly allocated to receive a single injection of a 5-component acellular or a whole cell pertussis vaccine, each combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine. Results, Although injection site redness greater than or equal to 50 mm and swelling greater than or equal to 50 mm were common in children who had received five doses of acellular (50% and 48.1%, respectively) or whole cell (66.2% and 59.7%) pertussis vaccine, limb soreness and limitation of motion were less frequently reported after acellular (1.9% and 0%) than after whole cell (49.2) and 36.3%; P < 0.0001) pertussis vaccine. Pre-fifth dose antipertussis antibody titers were higher in children who previously had received four doses of acellular pertussis vaccine. Postimmunization antibody titers against pertussis toxin, filamentous hemagglutinin, pertactin and tetanus toxin were higher in recipients of five doses of acellular pertussis vaccine, whereas antibody titers to diphtheria toxin, pertussis fimbriae and poliovirus serotypes were higher in recipients of five doses of the whole cell pertussis vaccine (P < 0.05 for all comparisons). Conclusions. A regimen consisting of five doses of a five component acellular pertussis combination vaccine is safe and immunogenic in preschool children. Local adverse reactions are common but are less painful and activity-limiting than a regimen of five doses of a whole cell pertussis vaccine.
引用
收藏
页码:772 / 779
页数:8
相关论文
共 33 条
[1]   CLINICAL AND SEROLOGIC RESPONSES TO ACELLULAR PERTUSSIS-VACCINE IN INFANTS AND YOUNG-CHILDREN [J].
ANDERSON, EL ;
BELSHE, RB ;
BARTRAM, J ;
GURWITH, M ;
HUNG, P ;
LEVNER, M ;
VERNON, SK .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (09) :949-953
[2]   COMPARISON OF A 3-COMPONENT ACELLULAR PERTUSSIS-VACCINE WITH A WHOLE-CELL PERTUSSIS-VACCINE IN 4-YEAR-OLD THROUGH 6-YEAR-OLD CHILDREN [J].
ANNUNZIATO, PW ;
ROTHSTEIN, EP ;
BERNSTEIN, HH ;
BLATTER, MM ;
REISINGER, KS ;
PICHICHERO, ME .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1994, 148 (05) :503-507
[3]  
[Anonymous], 1997, CAN COMMUN DIS REP, V23, P1
[4]   COMPARISON OF ACELLULAR PERTUSSIS-VACCINE WITH WHOLE CELL VACCINE AS A BOOSTER IN CHILDREN 15 TO 18 MONTHS AND 4 TO 6 YEARS OF AGE [J].
BERNSTEIN, DI ;
SMITH, VE ;
SCHIFF, GM ;
RATHFON, HM ;
BOSCIA, JA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (02) :131-135
[5]   CLINICAL REACTIONS AND IMMUNOGENICITY OF THE BIKEN ACELLULAR DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS-VACCINE IN 4-YEAR-OLD THROUGH 6-YEAR-OLD UNITED-STATES CHILDREN [J].
BERNSTEIN, HH ;
ROTHSTEIN, EP ;
PICHICHERO, ME ;
FRANCIS, AB ;
KOVEL, AJ ;
DISNEY, FA ;
GREEN, JL ;
MARSOCCI, SM ;
LYND, AM ;
WOOD, GC ;
SCHILLER, RP ;
GIRONE, JAC ;
HIPP, TJ ;
SOUDER, RL ;
KENNEDY, TI ;
MESCHIEVITZ, CK .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1992, 146 (05) :556-559
[6]  
BLENNOW M, 1989, PEDIATRICS, V84, P62
[7]  
CDC, 1996, MMWR-MORBID MORTAL W, V45, P676
[8]   A search for serologic correlates of immunity to Bordetella pertussis cough illnesses [J].
Cherry, JD ;
Gornbein, J ;
Heininger, U ;
Stehr, K .
VACCINE, 1998, 16 (20) :1901-1906
[9]  
CHERRY JD, 1989, WESTERN J MED, V150, P319
[10]   EVALUATION OF A NEW HIGHLY PURIFIED PERTUSSIS-VACCINE IN INFANTS AND CHILDREN [J].
EDWARDS, KM ;
BRADLEY, RB ;
DECKER, MD ;
PALMER, PS ;
VANSAVAGE, J ;
TAYLOR, JC ;
DUPONT, WD ;
HAGER, CC ;
WRIGHT, PF .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (05) :832-837